Editorial: New insights into inflammation driven autoimmune skin disorders: trends and challenges - Takeaways - MDSpire

Editorial: New insights into inflammation driven autoimmune skin disorders: trends and challenges

  • By

  • Manoj Kumar Tembhre

  • Alpana Sharma

  • Pankaj Dipankar

  • Shanid Mohiyuddin

  • Mohammad Tarique

  • Suneel Kumar

  • July 7, 2026

  • 0 min

Share

  • 1

    Skin serves as a dynamic organ for immune surveillance, with immune-privileged sites like hair follicles contributing to autoimmune skin disorders.

  • 2

    Keratinocytes play an active role in immune responses, influencing cytokine production and immune cell recruitment in various skin conditions.

  • 3

    Emerging immunotherapies for autoimmune skin disorders include JAK inhibitors and targeted therapies, shifting focus from generalized immunosuppression.

  • 4

    Neutrophil extracellular traps (NETs) have been implicated in autoimmune diseases like psoriasis, with potential therapeutic targets identified.

  • 5

    Selective targeting of the IL-23 p19 subunit has shown significant improvements in psoriasis treatment, enhancing skin clearance and quality of life.

Original Source(s)

Editorial: New insights into inflammation driven autoimmune skin disorders: trends and challenges

  • by Manoj Kumar Tembhre, Alpana Sharma, Pankaj Dipankar, Shanid Mohiyuddin, Mohammad Tarique, Suneel Kumar

  • July 7, 2026

Related Content

A systems-oriented Ayurvedic approach in chronic plaque psoriasis with renal inflammatory indicators: a 2-year longitudinal case report

FDA Expands Pediatric Roflumilast Use

The expanded indication is supported by pharmacokinetic, safety, tolerability, exploratory efficacy, and long-term safety data from studies in children aged 2 to 5 years.

GLP-1 Agents May Reduce Psoriasis Severity

National Psoriasis Foundation review highlights limited evidence and potential metabolic links.